Six months between injections. That is the rhythm lenacapavir is bringing to HIV prevention in South Africa, and nurses across the country are right now figuring out how to make that rhythm work in real clinics, with real patients.
Lenacapavir is a new injectable HIV prevention option given just twice a year, and its arrival means the healthcare workers closest to patients, the nurses, are the ones doing the heavy lifting of turning a clinical trial breakthrough into everyday care. That means new training, new techniques, and new conversations at the bedside.
Learning to administer the injection is only part of the work. Nurses are also adapting to the practical realities of their communities, thinking through how to track patients on a six-monthly schedule, how to explain the treatment clearly, and how to keep people coming back for their next dose.
What makes this moment significant is that lenacapavir places nurses at the center of one of the most promising shifts in HIV prevention in years. Their ability to adapt will shape how many South Africans actually benefit from it. Watch this space.
Originally published by AllAfrica.